These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20108169)
21. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Kim D; Cho SW; Her SJ; Yang JY; Kim SW; Kim SY; Shin CS Stem Cells; 2006 Jul; 24(7):1798-805. PubMed ID: 16556708 [TBL] [Abstract][Full Text] [Related]
22. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508 [TBL] [Abstract][Full Text] [Related]
23. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670 [TBL] [Abstract][Full Text] [Related]
24. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328 [TBL] [Abstract][Full Text] [Related]
25. Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice. Hankenson KD; James IE; Apone S; Stroup GB; Blake SM; Liang X; Lark MW; Bornstein P Matrix Biol; 2005 Aug; 24(5):362-70. PubMed ID: 15979292 [TBL] [Abstract][Full Text] [Related]
26. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss. Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498 [TBL] [Abstract][Full Text] [Related]
27. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis. Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183 [TBL] [Abstract][Full Text] [Related]
28. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss. Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773 [TBL] [Abstract][Full Text] [Related]
32. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice. Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688 [TBL] [Abstract][Full Text] [Related]
33. Colony-stimulating factor-1 and monocyte chemotactic protein-1 chemotaxis for monocytes in the rat dental follicle. Que BG; Wise GE Arch Oral Biol; 1997 Dec; 42(12):855-60. PubMed ID: 9460539 [TBL] [Abstract][Full Text] [Related]
34. Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure. Anginot A; Dacquin R; Mazzorana M; Jurdic P PLoS One; 2007 Jul; 2(7):e585. PubMed ID: 17611620 [TBL] [Abstract][Full Text] [Related]
35. CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice. Chen X; Ouyang Z; Shen Y; Liu B; Zhang Q; Wan L; Yin Z; Zhu W; Li S; Peng D RNA Biol; 2019 Sep; 16(9):1249-1262. PubMed ID: 31204558 [TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice. Fujita S; Kikuchi T; Sobue T; Suzuki M; Koide M; Noguchi T J Periodontol; 2008 Nov; 79(11):2173-81. PubMed ID: 18980527 [TBL] [Abstract][Full Text] [Related]
37. PDK2 Deficiency Prevents Ovariectomy-Induced Bone Loss in Mice by Regulating the RANKL-NFATc1 Pathway During Osteoclastogenesis. Lee JM; Kim MJ; Lee SJ; Kim BG; Choi JY; Lee SM; Ham HJ; Koh JM; Jeon JH; Lee IK J Bone Miner Res; 2021 Mar; 36(3):553-566. PubMed ID: 33125772 [TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680 [TBL] [Abstract][Full Text] [Related]
39. Ovariectomy increases RANKL protein expression in bone marrow adipocytes of C3H/HeJ mice. Beekman KM; Zwaagstra M; Veldhuis-Vlug AG; van Essen HW; den Heijer M; Maas M; Kerckhofs G; Parac-Vogt TN; Bisschop PH; Bravenboer N Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1050-E1054. PubMed ID: 31526291 [TBL] [Abstract][Full Text] [Related]
40. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC. Guo L; Chen K; Yuan J; Huang P; Xu X; Li C; Qian N; Qi J; Shao Z; Deng L; He C; Xu J J Cell Physiol; 2018 Jan; 234(1):581-594. PubMed ID: 30272823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]